NPM1 is now recognized as the most commonly mutated gene in patients with AML, occurring in approximately 30% of cases, and is strongly associated with de novo AML cases with a normal karyotype [45,46,47,48,49]. This evidence concerns the gene NPM1 and acute myeloid leukemia.